文章预览
SCI 26 October 2024 Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis (Journal of Thoracic Oncology; IF：21.0) Correspondence to: Dr. Filippo Tommaso Gallina, Thoracic Surgery Unit, IRCCS "Regina Elena" National Cancer Institute, Via Elio Chianesi, 53, 00128 Rome, Italy. filippo.gallina@ifo.it Marinelli D, Nuccio A, Di Federico A, Ambrosi F, Bertoglio P, Faccioli E, Ferrara R, Ferro A, Giusti R, Guerrera F, Mammana M, Pittaro A, Sepulcri M, Viscardi G, Gallina FT, Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis, Journal of Thoracic Oncology (2024), doi: https://doi.org/10.1016/j.jtho.2024.09.1443
………………………………
